We are live on ! Find out more
CCA

Column Capital Advisors Portfolio holdings

AUM $680M
1-Year Est. Return 15.16%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+15.16%
3 Year Est. Return
+20.42%
5 Year Est. Return
10 Year Est. Return
AUM
$603M
AUM Growth
+$119M
Cap. Flow
+$665M
Cap. Flow %
110.3%
Top 10 Hldgs %
64.49%
Holding
863
New
125
Increased
179
Reduced
80
Closed
23

Sector Composition

Rank Sector Weight
1 Real Estate 3.25%
2 Technology 2.94%
3 Healthcare 2.82%
4 Financials 1.59%
5 Consumer Discretionary 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTAS icon
526
Cintas
CTAS
$84.4B
$9.94K ﹤0.01%
88
+8
+10% +$865
AGM icon
527
Federal Agricultural Mortgage
AGM
$2.27B
$9.92K ﹤0.01%
+88
New +$10.1K
NOC icon
528
Northrop Grumman
NOC
$77.8B
$9.82K ﹤0.01%
18
+3
+20% +$1.56K
SCHF icon
529
Schwab International Equity ETF
SCHF
$65.9B
$9.75K ﹤0.01%
606
+12
+2% +$187
PAYX icon
530
Paychex
PAYX
$41.1B
$9.71K ﹤0.01%
84
HTZ icon
531
Hertz
HTZ
$632M
$9.66K ﹤0.01%
+628
New +$10.6K
IJK icon
532
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.9B
$9.56K ﹤0.01%
140
HZNP
533
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.56K ﹤0.01%
+84
New +$6.98K
CNR
534
Core Natural Resources Inc
CNR
$4.16B
$9.55K ﹤0.01%
147
-17
-10% -$1.15K
WDS icon
535
Woodside Energy
WDS
$41.4B
$9.49K ﹤0.01%
392
RSG icon
536
Republic Services
RSG
$66.7B
$9.42K ﹤0.01%
+73
New +$9.74K
BUD icon
537
AB InBev
BUD
$156B
$9.31K ﹤0.01%
155
ES icon
538
Eversource Energy
ES
$28.1B
$9.31K ﹤0.01%
111
CIVI
539
DELISTED
Civitas Resources
CIVI
$9.27K ﹤0.01%
+160
New +$10.3K
GRMN
540
Garmin
GRMN
$46.8B
$9.23K ﹤0.01%
100
WING icon
541
Wingstop
WING
$3.74B
$9.22K ﹤0.01%
+67
New +$9.89K
LDOS icon
542
Leidos
LDOS
$14.5B
$9.15K ﹤0.01%
87
NFJ
543
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.41B
$9.09K ﹤0.01%
806
UTZ icon
544
Utz Brands
UTZ
$1.25B
$9.06K ﹤0.01%
+571
New +$9.47K
CPK icon
545
Chesapeake Utilities
CPK
$3.26B
$8.98K ﹤0.01%
+76
New +$8.92K
PSO icon
546
Pearson
PSO
$10.1B
$8.8K ﹤0.01%
781
-489
-39% -$5.37K
HUM icon
547
Humana
HUM
$45.8B
$8.71K ﹤0.01%
17
ECL icon
548
Ecolab
ECL
$76.4B
$8.59K ﹤0.01%
59
IWO icon
549
iShares Russell 2000 Growth ETF
IWO
$14.4B
$8.58K ﹤0.01%
40
BAM icon
550
Brookfield Asset Management
BAM
$75.9B
$8.46K ﹤0.01%
+295
New +$8.88K

Similar funds

Column Capital Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Column Capital Advisors held 863 positions worth $603M, up 25% from $484M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Column Capital Advisors deployed $665M of net new capital in Q4 2022, opening 125 new positions and adding to 179 existing holdings. Its largest new stake was Moderna: 117,121 shares worth $119K.

By sector, the portfolio is most concentrated in Real Estate at 3.3% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 1000 ETF, an estimated $35.5M trimmed.

  • Column Capital Advisors's largest Q4 2022 buy was Moderna: 117,121 shares worth $119K.
  • Column Capital Advisors added most to Eli Lilly in Q4 2022, an estimated $269M increase.
  • Column Capital Advisors's biggest Q4 2022 reduction was iShares Russell 1000 ETF, cutting an estimated $35.5M.
  • Column Capital Advisors fully exited Duke Realty Corp. in Q4 2022, selling an estimated $11.9M.
  • Column Capital Advisors's ten largest holdings make up 64% of its $603M portfolio in Q4 2022.
  • Column Capital Advisors opened 125 new positions and closed 23 in Q4 2022.
  • Column Capital Advisors's portfolio value rose 25% quarter-over-quarter to $603M.

Based on Column Capital Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.